Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability

Sibeum Lee, Kyungwan Nam, Soo Kim Min, Wook Jun Seoung, Jeong Sook Park, Soo Woo Jong, Sung Joo Hwang

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

The objective of this study was to elucidate the feasibility to improve the solubility and bioavailability of poorly water-soluble itraconazole via solid dispersions by using supercritical fluid (SCF). Solid dispersions of itraconazole with hydrophilic polymer, HPMC 2910, were prepared by the aerosol solvent extraction system (ASES) under different process conditions of temperature/pressure. The particle size of solid dispersions ranged from 100 to 500 nm. The equilibrium solubility increased with decrease (15 to 10 MPa) in pressure and increase (40 to 60°C) in temperature. The solid dispersions prepared at 45°C/15 MPa showed a slight increase in equilibrium solubility (approximately 27-fold increase) when compared to pure itraconazole, while those prepared at 60°C/10 MPa showed approximately 610-fold increase and no endothermic peaks corresponding to pure itraconazole were observed, indicating that itraconazole might be molecularly dispersed in HPMC 2910 in the amorphous form. The amorphous state of itraconazole was confirmed by DSC/XRD data. The pharmacokinetic parameters of the ASES-processed solid dispersions, such as Tmax, Cmax, and AUC0-24h were almost similar to Sporanox® capsule which shows high bioavailability. Hence, it was concluded that the ASES process could be a promising technique to reduce particle size and/or prepare amorphous solid dispersion of drugs in order to improve the solubility and bioavailability of poorly water-soluble drugs.

Original languageEnglish
Pages (from-to)866-874
Number of pages9
JournalArchives of pharmacal research
Volume28
Issue number7
DOIs
Publication statusPublished - 2005 Jul 31

Fingerprint

Itraconazole
Solvent extraction
Aerosols
Dispersions
Solubility
Biological Availability
Pharmaceutical Preparations
Particle Size
Particle size
Pressure
Temperature
Pharmacokinetics
Supercritical fluids
Water
Capsules
Polymers

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery
  • Organic Chemistry

Cite this

@article{49ceedde3a9b4cc2a181560a5e5ae37f,
title = "Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability",
abstract = "The objective of this study was to elucidate the feasibility to improve the solubility and bioavailability of poorly water-soluble itraconazole via solid dispersions by using supercritical fluid (SCF). Solid dispersions of itraconazole with hydrophilic polymer, HPMC 2910, were prepared by the aerosol solvent extraction system (ASES) under different process conditions of temperature/pressure. The particle size of solid dispersions ranged from 100 to 500 nm. The equilibrium solubility increased with decrease (15 to 10 MPa) in pressure and increase (40 to 60°C) in temperature. The solid dispersions prepared at 45°C/15 MPa showed a slight increase in equilibrium solubility (approximately 27-fold increase) when compared to pure itraconazole, while those prepared at 60°C/10 MPa showed approximately 610-fold increase and no endothermic peaks corresponding to pure itraconazole were observed, indicating that itraconazole might be molecularly dispersed in HPMC 2910 in the amorphous form. The amorphous state of itraconazole was confirmed by DSC/XRD data. The pharmacokinetic parameters of the ASES-processed solid dispersions, such as Tmax, Cmax, and AUC0-24h were almost similar to Sporanox{\circledR} capsule which shows high bioavailability. Hence, it was concluded that the ASES process could be a promising technique to reduce particle size and/or prepare amorphous solid dispersion of drugs in order to improve the solubility and bioavailability of poorly water-soluble drugs.",
author = "Sibeum Lee and Kyungwan Nam and Min, {Soo Kim} and Seoung, {Wook Jun} and Park, {Jeong Sook} and Jong, {Soo Woo} and Hwang, {Sung Joo}",
year = "2005",
month = "7",
day = "31",
doi = "10.1007/BF02977355",
language = "English",
volume = "28",
pages = "866--874",
journal = "Archives of Pharmacal Research",
issn = "0253-6269",
publisher = "Pharmaceutical Society of Korea",
number = "7",

}

Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability. / Lee, Sibeum; Nam, Kyungwan; Min, Soo Kim; Seoung, Wook Jun; Park, Jeong Sook; Jong, Soo Woo; Hwang, Sung Joo.

In: Archives of pharmacal research, Vol. 28, No. 7, 31.07.2005, p. 866-874.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability

AU - Lee, Sibeum

AU - Nam, Kyungwan

AU - Min, Soo Kim

AU - Seoung, Wook Jun

AU - Park, Jeong Sook

AU - Jong, Soo Woo

AU - Hwang, Sung Joo

PY - 2005/7/31

Y1 - 2005/7/31

N2 - The objective of this study was to elucidate the feasibility to improve the solubility and bioavailability of poorly water-soluble itraconazole via solid dispersions by using supercritical fluid (SCF). Solid dispersions of itraconazole with hydrophilic polymer, HPMC 2910, were prepared by the aerosol solvent extraction system (ASES) under different process conditions of temperature/pressure. The particle size of solid dispersions ranged from 100 to 500 nm. The equilibrium solubility increased with decrease (15 to 10 MPa) in pressure and increase (40 to 60°C) in temperature. The solid dispersions prepared at 45°C/15 MPa showed a slight increase in equilibrium solubility (approximately 27-fold increase) when compared to pure itraconazole, while those prepared at 60°C/10 MPa showed approximately 610-fold increase and no endothermic peaks corresponding to pure itraconazole were observed, indicating that itraconazole might be molecularly dispersed in HPMC 2910 in the amorphous form. The amorphous state of itraconazole was confirmed by DSC/XRD data. The pharmacokinetic parameters of the ASES-processed solid dispersions, such as Tmax, Cmax, and AUC0-24h were almost similar to Sporanox® capsule which shows high bioavailability. Hence, it was concluded that the ASES process could be a promising technique to reduce particle size and/or prepare amorphous solid dispersion of drugs in order to improve the solubility and bioavailability of poorly water-soluble drugs.

AB - The objective of this study was to elucidate the feasibility to improve the solubility and bioavailability of poorly water-soluble itraconazole via solid dispersions by using supercritical fluid (SCF). Solid dispersions of itraconazole with hydrophilic polymer, HPMC 2910, were prepared by the aerosol solvent extraction system (ASES) under different process conditions of temperature/pressure. The particle size of solid dispersions ranged from 100 to 500 nm. The equilibrium solubility increased with decrease (15 to 10 MPa) in pressure and increase (40 to 60°C) in temperature. The solid dispersions prepared at 45°C/15 MPa showed a slight increase in equilibrium solubility (approximately 27-fold increase) when compared to pure itraconazole, while those prepared at 60°C/10 MPa showed approximately 610-fold increase and no endothermic peaks corresponding to pure itraconazole were observed, indicating that itraconazole might be molecularly dispersed in HPMC 2910 in the amorphous form. The amorphous state of itraconazole was confirmed by DSC/XRD data. The pharmacokinetic parameters of the ASES-processed solid dispersions, such as Tmax, Cmax, and AUC0-24h were almost similar to Sporanox® capsule which shows high bioavailability. Hence, it was concluded that the ASES process could be a promising technique to reduce particle size and/or prepare amorphous solid dispersion of drugs in order to improve the solubility and bioavailability of poorly water-soluble drugs.

UR - http://www.scopus.com/inward/record.url?scp=30544435685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30544435685&partnerID=8YFLogxK

U2 - 10.1007/BF02977355

DO - 10.1007/BF02977355

M3 - Article

C2 - 16114503

AN - SCOPUS:30544435685

VL - 28

SP - 866

EP - 874

JO - Archives of Pharmacal Research

JF - Archives of Pharmacal Research

SN - 0253-6269

IS - 7

ER -